Welcome to the May issue of ePathWay
ePathway is an e-magazine designed for anyone interested in their health and wellbeing and the integral role pathology plays in the diagnosis, treatment and management of diseases.
This month’s issue of ePathway looks at the following:
- Measles: the importance of highly vaccinated population
- Candida auris, an emerging global health threat
- Allergies and asthma, a serious public health issue
- Precision medicine through cancer proteomics
Measles is a highly contagious viral illness which can cause serious, sometimes fatal complications. With the number of measles cases increasing in recent years, and a number of countries experiencing severe and prolonged measles outbreaks, we spoke to Professor William Rawlinson who explained the importance of maintaining a highly vaccinated population.
Recent reports have identified an emerging global health threat which has been causing severe illness in hospitalised patients. Candida auris (C. auris) is a new, uncommon fungus which causes invasive, life-threatening bloodstream infections and is often resistant to multiple antifungal medications. Doctor Michael Thomas took the time to speak with us to provide a more detailed background on this new health threat.
The rapid increase of allergic diseases over the past few decades has become a serious public health issue in Australia and New Zealand. To coincide with asthma awareness week, we spoke with Doctor Daman Langguth to discuss the impact that allergies can have on asthma. Many of those people diagnosed with asthma, have also tested positive for allergies, and so in order to treat asthma effectively, it is important that the allergy is also considered.
Finally, we spoke to Professor Roger Reddel to learn more about his research into proteomics. Proteomics is referred to as the newest frontier of medical research and refers to the study of proteomes – the entire sum of proteins that is or can be expressed by a cell, tissue, or organism. ProCan will analyse thousands of proteins in 50,000 cancers of all types over the next 5-7 years and aims to help scientists all over the world studying cancer through a vast, publicly-available database.
Remember to follow us on Facebook (@TheRoyalCollegeofPathologistsofAustralasia), Twitter (@PathologyRCPA) or on Instagram (@the_rcpa). CEO, Dr Debra Graves can be followed on Twitter too (@DebraJGraves).
The number of measles cases worldwide has increased substantially in very recent years, with a number of countries currently experiencing severe and prolonged measles outbreaks. We spoke to Professor William Rawlinson, Senior Medical Virologist, Director of Serology, Virology and OTDS Laboratories (SAViD) at NSW Health Pathology Randwick, to discuss the importance of maintaining a highly vaccinated population to prevent this highly contagious viral illness which can cause serious, sometimes fatal complications.
read more »
Candida auris (C. auris) is a new, uncommon fungus which has emerged as a serious global health threat, largely due to the fact that it is multidrug-resistant. First recognised in Japan, C. auris has since been reported by healthcare facilities in a number of countries, causing severe illness in hospitalized patients. We spoke to Dr Michael Thomas, microbiologist at Pathology Queensland Gold Coast, to discuss this relatively new threat.
read more »
Allergies and asthma are very common in Australia and New Zealand, with one in five people developing allergies at some time in their life. To coincide with asthma awareness week which took place this month, we spoke with Doctor Daman Langguth, Head of the Immunology Department at Sullivan Nicolaides Pathology, Brisbane to discuss the effect that allergies can have on asthma.
read more »
We spoke to Professor Roger Reddel to discuss his presentation at this year’s Pathology Update 2019, ‘Diagnoses through cancer proteomics – PROCAN.’ Prof Reddel has been Director of Children's Medical Research Institute (CMRI), and the Sir Lorimer Dods Professor, Sydney Medical School, University of Sydney, since 2007. He is also Head of CMRI's Cancer Research Unit, Director of CellBank Australia and Co-Director of ProCan®.
read more »